Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility

被引：0
|
作者：
Dorota Fiszer
Nickla A Fisher
Ian M Carr
Marie-Anne Shaw
Philip M Hopkins
机构：
[1] School of Medicine,Leeds Institute of Biomedical & Clinical Sciences
[2] University of Leeds,Malignant Hyperthermia Investigation Unit
[3] St James’s University Hospital,undefined
来源：
BMC Anesthesiology | / 14卷 / Suppl 1期
关键词：
Malignant Hyperthermia; Malignant Hyperthermia; Massive Parallel Sequencing; Malignant Hyperthermia Susceptibility; Exertional Heat Stroke;
D O I：
10.1186/1471-2253-14-S1-A13
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Bayesian modeling to predict malignant hyperthermia susceptibility and pathogenicity of RYR1, CACNA1S and STAC3 variants
    Sadhasivam, Senthilkumar
    Brandom, Barbara W.
    Henker, Richard A.
    McAuliffe, John J.
    PHARMACOGENOMICS, 2019, 20 (14) : 989 - 1003
  • [2] Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia
    Schiemann, A. H.
    Stowell, K. M.
    BRITISH JOURNAL OF ANAESTHESIA, 2016, 117 (01) : 124 - 128
  • [3] Updating probability of pathogenicity for RYR1 and CACNA1S exon variants in individuals without malignant hyperthermia after exposure to triggering anesthetics
    Roberts, David A.
    Bastarache, Lisa
    He, Jing
    Lewis, Adam
    Aka, Ida T.
    Shotwell, Matthew S.
    Reddy, Srijaya K.
    Hogan, Kirk J.
    Biesecker, Leslie G.
    Kertai, Miklos D.
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (02) : 65 - 72
  • [4] RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms
    Isackson, Paul J.
    Wang, Jianxin
    Zia, Mohammad
    Spurgeon, Paul
    Levesque, Adrian
    Bard, Jonathan
    James, Smitha
    Nowak, Norma
    Lee, Tae Keun
    Vladutiu, Georgirene D.
    PHARMACOGENOMICS, 2018, 19 (16) : 1235 - 1249
  • [5] Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia
    Beam, Teresa A.
    Loudermilk, Emily F.
    Kisor, David F.
    PHYSIOLOGICAL GENOMICS, 2017, 49 (02) : 81 - 87
  • [6] Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia
    White, Ruth
    Schiemann, Anja H.
    Burling, Sophie M.
    Bjorksten, Andrew
    Bulger, Terasa
    Gillies, Robyn
    Hopkins, Philip M.
    Kamsteeg, Erik-Jan
    Machon, Roslyn G.
    Massey, Sean
    Miller, Dorota
    Perry, Margaret
    Snoeck, Marc M. J.
    Stephens, Jeremy
    Street, Neil
    van den Bersselaar, Luuk R.
    Stowell, Kathryn M.
    BRITISH JOURNAL OF ANAESTHESIA, 2022, 129 (06) : 879 - 888
  • [7] How mutations in RYR1 that cause malignant hyperthermia increase RYR1 sensitivity to activators
    Baker, Matthew L.
    Dirksen, Robert T.
    Hamilton, Susan L.
    CELL CALCIUM, 2021, 97
  • [8] No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population
    Brooks, C
    Robinson, RL
    Halsall, PJ
    Hopkins, PM
    BRITISH JOURNAL OF ANAESTHESIA, 2002, 88 (04) : 587 - 589
  • [9] Assessing the pathogenicity of RYR1 variants in malignant hyperthermia
    Merritt, A.
    Booms, P.
    Shaw, M-A.
    Miller, D. M.
    Daly, C.
    Bilmen, J. G.
    Stowell, K. M.
    Allen, P. D.
    Steele, D. S.
    Hopkins, P. M.
    BRITISH JOURNAL OF ANAESTHESIA, 2017, 118 (04) : 533 - 543
  • [10] Genetic variation in RYR1 and malignant hyperthermia phenotypes
    Carpenter, D.
    Robinson, R. L.
    Quinnell, R. J.
    Ringrose, C.
    Hogg, M.
    Casson, F.
    Booms, P.
    Iles, D. E.
    Halsall, P. J.
    Steele, D. S.
    Shaw, M. -A.
    Hopkins, P. M.
    BRITISH JOURNAL OF ANAESTHESIA, 2009, 103 (04) : 538 - 548
12345